Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
156.2 USD | -7.00% | -5.28% | -13.41% |
21/05 | Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India | MT |
14/05 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.41% | 1.76TCr | |
+10.79% | 12TCr | |
+11.65% | 11TCr | |
-6.20% | 2.47TCr | |
-2.33% | 2.2TCr | |
-6.03% | 1.93TCr | |
-40.50% | 1.73TCr | |
+6.64% | 1.4TCr | |
+31.84% | 1.21TCr | |
-34.35% | 776.53Cr |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- BeiGene : Swings to Profit in Q1 as Revenue Soars to $606 Million